دورية
A pilot in vivoproton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder
| العنوان: | A pilot in vivoproton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder |
|---|---|
| المؤلفون: | Milak, M S, Proper, C J, Mulhern, S T, Parter, A L, Kegeles, L S, Ogden, R T, Mao, X, Rodriguez, C I, Oquendo, M A, Suckow, R F, Cooper, T B, Keilp, J G, Shungu, D C, Mann, J J |
| المصدر: | Molecular Psychiatry; March 2016, Vol. 21 Issue: 3 p320-327, 8p |
| مستخلص: | The N-methyl-D-aspartate receptor antagonist ketamine can improve major depressive disorder (MDD) within hours. To evaluate the putative role of glutamatergic and GABAergic systems in ketamine’s antidepressant action, medial prefrontal cortical (mPFC) levels of glutamate+glutamine (Glx) and ?-aminobutyric acid (GABA) were measured before, during, and after ketamine administration using proton magnetic resonance spectroscopy. Ketamine (0.5?mg kg-1intravenously) was administered to 11 depressed patients with MDD. Glx and GABA mPFC responses were measured as ratios relative to unsuppressed voxel tissue water (W) successfully in 8/11 patients. Ten of 11 patients remitted (50% reduction in 24-item Hamilton Depression Rating Scale and total score ?10) within 230?min of commencing ketamine. mPFC Glx/W and GABA/W peaked at 37.8%±7.5% and 38.0%±9.1% above baseline in ~26?min. Mean areas under the curve for Glx/W (P=0.025) and GABA/W (P=0.005) increased and correlated (r=0.796; P=0.018). Clinical improvement correlated with 90-min norketamine concentration (df=6, r=-0.78, P=0.023), but no other measures. |
| قاعدة البيانات: | Supplemental Index |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 13594184 14765578 |
|---|---|
| DOI: | 10.1038/mp.2015.83 |